Search hospitals > Nebraska > Kearney
Heartland Hematology and Oncology
Claim this profileKearney, Nebraska 68845
Global Leader in Thyroid Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Relapse
Conducts research for Breast cancer
101 reported clinical trials
2 medical researchers
Summary
Heartland Hematology and Oncology is a medical facility located in Kearney, Nebraska. This center is recognized for care of Thyroid Cancer, Lung Cancer, Breast Cancer, Relapse, Breast cancer and other specialties. Heartland Hematology and Oncology is involved with conducting 101 clinical trials across 314 conditions. There are 2 research doctors associated with this hospital, such as Richard L. Deming and Mehmet S. Copur.Area of expertise
1Thyroid Cancer
Global LeaderStage IV
Stage I
Stage III
2Lung Cancer
Global LeaderStage IV
Stage II
Stage I
Top PIs
Richard L. DemingMercy Medical Center - Des Moines6 years of reported clinical research
Expert in Thyroid Cancer
Expert in Breast Cancer
178 reported clinical trials
242 drugs studied
Mehmet S. CopurBethesda North Hospital13 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
3 reported clinical trials
14 drugs studied
Clinical Trials running at Heartland Hematology and Oncology
Lung Cancer
Testicular cancer
Thyroid Cancer
Ovarian Tumors
Ovarian Choriocarcinoma
Ovarian Carcinoma
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Testicular Choriocarcinoma
Testicular Carcinoma
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Heartland Hematology and Oncology?
Heartland Hematology and Oncology is a medical facility located in Kearney, Nebraska. This center is recognized for care of Thyroid Cancer, Lung Cancer, Breast Cancer, Relapse, Breast cancer and other specialties. Heartland Hematology and Oncology is involved with conducting 101 clinical trials across 314 conditions. There are 2 research doctors associated with this hospital, such as Richard L. Deming and Mehmet S. Copur.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.